Doxorubicin Inhibits Proliferation of Osteosarcoma Cells Through Upregulation of the Notch Signaling Pathway

Overview

Journal Oncol Res

Specialty Oncology

Date 2015 Sep 10

PMID 26351207

Citations 9

Authors

Peng Ji

Ling Yu

Wei-Chun Guo

Hong-Jun Mei

Xiao-Ju Wang

Hu Chen

Shuo Fang

Jian Yang

Affiliations

Soon will be listed here.

Abstract

Doxorubicin plays a major role in the treatment of osteosarcoma disorders. The Notch signaling pathway exerts various biological functions, including cell proliferation, differentiation, and apoptosis. In the present study, we investigated the effects of different doses of doxorubicin on proliferation and apoptosis of osteosarcoma cells with or without Notch signaling. Results found that cellular viability was downregulated while caspase 3 activity and expression were promoted in osteosarcoma cells following treatment with various doses of doxorubicin for 24, 48, and 72 h, and the effects showed a dose- and time-dependent manner. Furthermore, it was found that various doses of doxorubicin activated the Notch signaling pathway, shown by the elevated expression of Notch target genes NOTCH1, HEY1, HES1, AND HES5. It was further proved that, after small interfering RNA (siRNA)-mediated knockdown of Notch, the effects of doxorubicin on the viability and apoptosis of osteosarcoma cells were significantly reduced. It was indicated that doxorubicin treatment reduced the proliferation and promoted the apoptosis of osteosarcoma cells, and this effect was mediated by the Notch signaling pathway.

Citing Articles

Molecular effects of clinically relevant chemotherapeutic agents on choline phospholipid metabolism in triple negative breast cancer cells.

Tressler C, Sonkar K, Cheng M, Ayyappan V, Cai R, Glunde K Transl Oncol. 2025; 53:102311.

PMID: 39922048 PMC: 11849126. DOI: 10.1016/j.tranon.2025.102311.

Tellurium-Doped Bioactive Glass Induces Ferroptosis in Osteosarcoma Cells Regardless of FSP1.

Panczyszyn E, Lallukka M, Gagliardi M, Saverio V, Monzani R, Miola M Antioxidants (Basel). 2024; 13(11).

PMID: 39594469 PMC: 11591201. DOI: 10.3390/antiox13111327.

Self-Renewal and Pluripotency in Osteosarcoma Stem Cells' Chemoresistance: Notch, Hedgehog, and Wnt/β-Catenin Interplay with Embryonic Markers.

Martins-Neves S, Sampaio-Ribeiro G, Gomes C Int J Mol Sci. 2023; 24(9).

PMID: 37176108 PMC: 10179672. DOI: 10.3390/ijms24098401.

Targeting Notch to Maximize Chemotherapeutic Benefits: Rationale, Advanced Strategies, and Future Perspectives.

Zhdanovskaya N, Firrincieli M, Lazzari S, Pace E, Scribani Rossi P, Felli M Cancers (Basel). 2021; 13(20).

PMID: 34680255 PMC: 8533696. DOI: 10.3390/cancers13205106.

Chlorogenic Acid Enhances Doxorubicin-Mediated Cytotoxic Effect in Osteosarcoma Cells.

Salzillo A, Ragone A, Spina A, Naviglio S, Sapio L Int J Mol Sci. 2021; 22(16).

PMID: 34445291 PMC: 8395331. DOI: 10.3390/ijms22168586.

References

Jacobson M, Weil M, Raff M . Programmed cell death in animal development. Cell. 1997; 88(3):347-54. DOI: 10.1016/s0092-8674(00)81873-5. View

Yamamoto H, Oshiro R, Nishimura J, Uemura M, Haraguchi N, Hata T . Low-dose dacarbazine-doxorubicin therapy against intra-abdominal desmoid tumors. Oncol Rep. 2013; 29(5):1751-5. DOI: 10.3892/or.2013.2345. View

Damodar G, Smitha T, Gopinath S, Vijayakumar S, Rao Y . An evaluation of hepatotoxicity in breast cancer patients receiving injection Doxorubicin. Ann Med Health Sci Res. 2014; 4(1):74-9. PMC: 3952301. DOI: 10.4103/2141-9248.126619. View

Vici P, Pizzuti L, Gamucci T, Sergi D, Conti F, Zampa G . Non-pegylated liposomal Doxorubicin-cyclophosphamide in sequential regimens with taxanes as neoadjuvant chemotherapy in breast cancer patients. J Cancer. 2014; 5(6):398-405. PMC: 4026993. DOI: 10.7150/jca.9132. View

Duggan S, Keating G . Pegylated liposomal doxorubicin: a review of its use in metastatic breast cancer, ovarian cancer, multiple myeloma and AIDS-related Kaposi's sarcoma. Drugs. 2011; 71(18):2531-58. DOI: 10.2165/11207510-000000000-00000. View

Ma Y, Ren Y, Han E, Li H, Chen D, Jacobs J . Inhibition of the Wnt-β-catenin and Notch signaling pathways sensitizes osteosarcoma cells to chemotherapy. Biochem Biophys Res Commun. 2013; 431(2):274-9. PMC: 3710725. DOI: 10.1016/j.bbrc.2012.12.118. View

Lobry C, Oh P, Mansour M, Look A, Aifantis I . Notch signaling: switching an oncogene to a tumor suppressor. Blood. 2014; 123(16):2451-9. PMC: 3990910. DOI: 10.1182/blood-2013-08-355818. View

McManus M, Weiss K, Hughes D . Understanding the role of Notch in osteosarcoma. Adv Exp Med Biol. 2014; 804:67-92. DOI: 10.1007/978-3-319-04843-7_4. View

Rampias T, Vgenopoulou P, Avgeris M, Polyzos A, Stravodimos K, Valavanis C . A new tumor suppressor role for the Notch pathway in bladder cancer. Nat Med. 2014; 20(10):1199-205. DOI: 10.1038/nm.3678. View

10.

Tanaka M, Setoguchi T, Hirotsu M, Gao H, Sasaki H, Matsunoshita Y . Inhibition of Notch pathway prevents osteosarcoma growth by cell cycle regulation. Br J Cancer. 2009; 100(12):1957-65. PMC: 2714252. DOI: 10.1038/sj.bjc.6605060. View

11.

Martins L, Kottke T, Mesner P, Basi G, Sinha S, Frigon Jr N . Activation of multiple interleukin-1beta converting enzyme homologues in cytosol and nuclei of HL-60 cells during etoposide-induced apoptosis. J Biol Chem. 1997; 272(11):7421-30. DOI: 10.1074/jbc.272.11.7421. View

12.

Hansen A, Hughes B, Paul S, Steadman P, Sommerville S, Dickinson I . Single institution retrospective review of perioperative chemotherapy in adult and adolescent patients with operable osteosarcoma. Asia Pac J Clin Oncol. 2014; 12(2):e222-8. DOI: 10.1111/ajco.12167. View

13.

Hughes D . How the NOTCH pathway contributes to the ability of osteosarcoma cells to metastasize. Cancer Treat Res. 2010; 152:479-96. DOI: 10.1007/978-1-4419-0284-9_28. View

14.

Ritter J, Bielack S . Osteosarcoma. Ann Oncol. 2010; 21 Suppl 7:vii320-5. DOI: 10.1093/annonc/mdq276. View

15.

Nicholson D, Thornberry N . Caspases: killer proteases. Trends Biochem Sci. 1997; 22(8):299-306. DOI: 10.1016/s0968-0004(97)01085-2. View

16.

Kwon O, Valdez J, Zhang L, Zhang B, Wei X, Su Q . Increased Notch signalling inhibits anoikis and stimulates proliferation of prostate luminal epithelial cells. Nat Commun. 2014; 5:4416. PMC: 4167399. DOI: 10.1038/ncomms5416. View

17.

Ai X, Jia Z, Liu S, Wang J, Zhang X . Notch-1 regulates proliferation and differentiation of human bladder cancer cell lines by inhibiting expression of Krüppel-like factor 4. Oncol Rep. 2014; 32(4):1459-64. DOI: 10.3892/or.2014.3350. View

18.

He H, Ni J, Huang J . Molecular mechanisms of chemoresistance in osteosarcoma (Review). Oncol Lett. 2014; 7(5):1352-1362. PMC: 3997672. DOI: 10.3892/ol.2014.1935. View

19.

Pecoraro M, Sorrentino R, Franceschelli S, Del Pizzo M, Pinto A, Popolo A . Doxorubicin-Mediated Cardiotoxicity: Role of Mitochondrial Connexin 43. Cardiovasc Toxicol. 2015; 15(4):366-76. DOI: 10.1007/s12012-014-9305-8. View

20.

Yan B, Liu L, Zhao Y, Xiu L, Sun D, Liu X . Xiaotan Sanjie decoction attenuates tumor angiogenesis by manipulating Notch-1-regulated proliferation of gastric cancer stem-like cells. World J Gastroenterol. 2014; 20(36):13105-18. PMC: 4177489. DOI: 10.3748/wjg.v20.i36.13105. View